News

During the month of November, 2020, USAID (GHSC-QA) has audited Imres BV as part of the regular audit schedule to re-certify procurement agencies and wholesalers. Based on the exceptionally positive outcome, Imres has been informed that we continue to be fully compliant with WHO TRS 986, annex 3...

While in some countries the COVID-19 pandemic moves towards a flattening curve, there is still a great need for medicines and medical supplies, especially in the low resource economies. Imres is proud to be able to help by supplying essential medicines and medical consumables. On request, we...

Dear Customer, This statement is in reference to the COVID-19 outbreak. The COVID-19 pandemic has affected many countries globally. In line with our mandate, Imres is supporting our partners in vulnerable countries and regions of the world that need support while increasing preparedness...

Dear Customer, This statement is in reference to the COVID-19 outbreak. The COVID-19 pandemic has affected many countries globally. In line with our mandate, we are supporting our partners in vulnerable countries and regions of the world that need support while increasing preparedness or...

From the 1st of January 2020, Leontien Ruttenberg has been appointed as Managing Director for Imres B.V., the Netherlands. Mr. Niek Zee, former Managing Director of Imres, has retired as of the 31st of December 2019. Niek will continue to serve on the Imres Supervisory Board. Leontien,...

As of February 9th, the European Falsified Medicines Directive (EU FMD) will become effective. The EU FMD is put in place to counteract the circulation of falsified medicines in Europe. All medicines require a unique identifier printed on each and every package. In addition, all medicines...